Helius Medical Technologies (HSDT)

• Market cap: $1.84M
• 1 day: -5.87%
• 5 days: -10.45%
• 1 month: 37.64%
• 3 months: -26.72%
• 6 months: -67.20%
• Year to date: -93.64%
• 1 year: -92.57%
• 5 years: -99.96%
• 10 years: -100.00%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Employees: 22

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

3.9% less ownership

Funds ownership: 6.16% [Q2] → 2.26% (-3.9%) [Q3]

7% less funds holding

Funds holding: 15 [Q2] → 14 (-1) [Q3]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less capital invested

Capital invested by funds: $179K [Q2] → $45.3K (-$134K) [Q3]